| Literature DB >> 31155483 |
Daniela Cornacchia1, Chao Zhang2, Bastian Zimmer1, Sun Young Chung1, Yujie Fan3, Mohamed A Soliman4, Jason Tchieu1, Stuart M Chambers1, Hardik Shah5, Daniel Paull6, Csaba Konrad7, Michelle Vincendeau1, Scott A Noggle6, Giovanni Manfredi7, Lydia W S Finley8, Justin R Cross5, Doron Betel2, Lorenz Studer9.
Abstract
Current challenges in capturing naive human pluripotent stem cells (hPSCs) suggest that the factors regulating human naive versus primed pluripotency remain incompletely defined. Here we demonstrate that the widely used Essential 8 minimal medium (E8) captures hPSCs at a naive-to-primed intermediate state of pluripotency expressing several naive-like developmental, bioenergetic, and epigenomic features despite providing primed-state-sustaining growth factor conditions. Transcriptionally, E8 hPSCs are marked by activated lipid biosynthesis and suppressed MAPK/TGF-β gene expression, resulting in endogenous ERK inhibition. These features are dependent on lipid-free culture conditions and are lost upon lipid exposure, whereas short-term pharmacological ERK inhibition restores naive-to-primed intermediate traits even in the presence of lipids. Finally, we identify de novo lipogenesis as a common transcriptional signature of E8 hPSCs and the pre-implantation human epiblast in vivo. These findings implicate exogenous lipid availability in regulating human pluripotency and define E8 hPSCs as a stable, naive-to-primed intermediate (NPI) pluripotent state.Entities:
Keywords: differential human pluripotent states; endogenous ERK inhibition; lipid metabolism; metabolic regulation of cell identity; metabolism and epigenetics; metabolism and pluripotency; naive-to-primed intermediate pluripotency; pluripotency regulation through lipids
Year: 2019 PMID: 31155483 DOI: 10.1016/j.stem.2019.05.001
Source DB: PubMed Journal: Cell Stem Cell ISSN: 1875-9777 Impact factor: 24.633